0.00Open0.00Pre Close0 Volume0 Open Interest1.50Strike Price0.00Turnover0.00%IV-60.63%PremiumAug 16, 2024Expiry Date2.31Intrinsic Value100Multiplier25DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma1.66Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Arbutus Biopharma Stock Discussion
Based on preliminary end-of-treatment data, Arbutus said that the therapy resulted in maintenance of lower hepatitis B surface antigen levels during the post-treatment follow-up period.
...
Treatment with Arbutus’ Imdusiran and VTP-300 Achieves Statistical Significance in Lowering HBsAg Levels
Arbutus Biopharma (Nasdaq: ABUS) has announced promising new data presented at the European Association for the Study of the Liver (EASL) Congress regarding its RNAi therapeutic, Imdusiran, combined with the T-cell stimulating immunotherapeutic VTP-300. The Phase 2a trial showed significant reductions in Hepatitis B surface antigen (HBsAg) levels. At 24-weeks ...
$Iovance Biotherapeutics(IOVA.US)$ Phase 2
$Supernus Pharmaceuticals(SUPN.US)$ Phase 2a
$BRANDES INTERNATIONAL ETF(BINV.US)$ Phase 2a
$MorphoSys(MOR.US)$ Phase 2
$Nuvation Bio(NUVB.US)$ Phase 2
$ALX Oncology(ALXO.US)$ Phase 2
$BioXcel Therapeutics(BTAI.US)$ Phase 2
$Purple Biotech(PPBT.US)$ Phase 2
$Arcus Biosciences(RCUS.US)$ Phase 2
$Medicenna Therapeutics(MDNAF.US)$ Phase 2b
$Affimed NV(AFMD.US)$ Phase 2
$Barinthus Biotherapeutics(BRNS.US)$ Phase 2b...
In reaction to earnings/guidance:
• $Super Micro Computer(SMCI.US)$ +18%, $Nokia Oyj(NOK.US)$ +7.7%, $Danaher(DHR.US)$ +6.3%, $RLI Corp(RLI.US)$ +5%, $CSX Corp(CSX.US)$ +4.3%, $Las Vegas Sands(LVS.US)$ +4.2%, $Alcoa(AA.US)$ +3.4%(also authorizes new $500 mln share repurchase program)
• $Steel Dynamics(STLD.US)$ +2.8%, $Herc Holdings(HRI.US)$ +2.6%, $Tesla(TSLA.US)$ +2.5%, $Philip Morris International(PM.US)$ +2.5%, $F.N.B. Corp(FNB.US)$ ...
$Nokia Oyj(NOK.US)$ $Arbutus Biopharma(ABUS.US)$
• $Red Robin(RRGB.US)$ +13.8% (In reaction to earnings)
• $PMV Pharmaceuticals(PMVP.US)$ +11.2% (ASCO-related announcement)
• $Sumo Logic(SUMO.US)$ +10.8% (In reaction to earnings)
• $Adicet Bio(ACET.US)$ +9.6% (ASCO-related announcement)
• $Dell Technologies(DELL.US)$ +9.6% (In reaction to earnings)
• $ImmunoGen(IMGN.US)$ +8.7% (ASCO-related announcement)
• $Ulta Beauty(ULTA.US)$ +7.9% (In reaction to earnings)
• $Zymergen(ZY.US)$ +7.8% (to...
No comment yet